secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001104659-22-107408
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio appoints William Chou as CEO, replacing interim CEO Chip Cale
-------------------------------------------------------------------------

- William Chou appointed CEO and director effective October 10, 2022.
- Edgar B. Cale resigned as interim CEO; continues as General Counsel and Corporate Secretary.
- Dr. Chou receives $580k base salary, 55% target bonus, and $200k sign-on bonus with clawback.
- Granted option to purchase 885,000 shares vesting over 4 years.
- Severance includes 12 months base salary plus bonus on termination without cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/0001104659-22-107408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/tm2227279d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-107408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer